Title | Description |
|---|---|
| Trial ID | KF7013-03 |
| Compound | Neridronic Acid |
| Trials sponsor | Grünenthal GmbH |
| Trial phase | 3 |
| Brief title | Safety of Intravenous Neridronic Acid in CRPS |
| Indication | Complex Regional Pain Syndrome (CRPS) |
| UTN | U1111-1180-8099 |
| CTG ID | NCT02972359 |
| CTIS ID (former EudraCT) | 2016-001164-11 |
| Trial status | Completed |
| FPI | December 20, 2016 |
| LPO | January 9, 2019 |
| Countries | Germany, United States |
| Gender | All |
| Age | >18 |
| Results | Yes |
| Pubmed | 19414839 |
| Documents | kf7013-03-lay-summary-english kf7013-03-lay-summary-german kf7013-03-expert-summary |
External Link
You are now leaving the Grünenthal website. You will be re-directed to an external website. Grünenthal accepts no responsibility for the content of other websites.